188Rhenium-EDTMP: A potential therapeutic bone agent |
| |
Authors: | S Pervez A Mushtaq N Arif Z H Chohan |
| |
Institution: | (1) Isotope Production Division, Pakistan Institute of Nuclear Science and Technology, P.O. Box, Nilore, Islamabad, Pakistan;(2) Department of Chemistry, Bahauddin Zakariya University, Multan, Pakistan;(3) Department of Chemistry, Islamia University, Bahawalpur, Pakistan |
| |
Abstract: | Bone seeking radiopharmaceuticals such as ethylenediaminetetramethylene phosphonate (EDTMP) complexes of 153Sm and 166Ho are receiving considerable attention for therapeutic treatment of bone metastases. Rhenium-188 has both beta-particle emissions for a therapeutic effect and gamma-emissions for imaging and it is available from an in-house generator system similar to the current 99mTc generator, which makes it convenient for clinical use. The preparation of 188Re-EDTMP is described using 188Re, which was obtained from the alumina-based 188W/188Re generator. Dependence of the radiolabeling yield of 188Re-EDTMP on reducing agent concentration, EDTMP concentration, incubation time, pH and addition of carrier was examined. In the case of optimum conditions, the radiolabeling yields of 188Re-EDTMP were ~98% for carrier-free as well as carrier-added 188Re. The addition of ascorbic acid plays an important role in the stability of carrier-free as well as carrier-added 188Re-EDTMP preparations. The biodistribution of carrier-free and carrier-added 188Re-EDTMP compounds in rats was also studied. The results show that 188Re (carrier-added)-EDTMP is a potential bone pain palliation radiopharmaceutical due to its high skeletal uptake, rapid blood clearance and relatively low soft tissue absorption. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|